Type 1 diabetes (English Wikipedia)

Smith & Harris 2018, "Self monitoring". Smith A, Harris C (August 2018). "Type 1 diabetes: Management strategies". American Family Physician. 98 (3): 154–156. PMID 30215903. Retrieved 12 January 2022.

aihw.gov.au

Australian Institute of Health and Welfare (2015). "Incidence of type 1 diabetes in Australia 2000–2013". Archived from the original on 7 October 2016. Retrieved 19 October 2016.

ajmc.com

McNulty R (7 October 2023). "Many Cases of Adult-Onset T1D Are Diagnosed After Age 30, Study Finds". ajmc. Retrieved 29 April 2024.

books.google.com

Skyler J (2012). Atlas of diabetes (4th ed.). New York: Springer. pp. 67–68. ISBN 978-1-4614-1028-7. Archived from the original on 8 September 2017.

cdc.gov

"What is Type 1 Diabetes?". Centers for Disease Control and Prevention. 11 March 2022. Retrieved 15 February 2023.

diabetes.co.uk

"Sexual Dysfunction in Women". Diabetes.co.uk. Diabetes Digital Media Ltd. Archived from the original on 9 November 2014. Retrieved 28 November 2014.

diabetes.org

"DKA (Ketoacidosis) & Ketones". American Diabetes Association. Retrieved 28 July 2021.
"Stress". diabetes.org. American Diabetes Association. Archived from the original on 12 November 2014. Retrieved 11 November 2014.
"Hypoglycemia (Low blood sugar)". American Diabetes Association. Retrieved 20 March 2022.

professional.diabetes.org

"Fast Facts Data and Statistics about Diabetes". American Diabetes Association. Archived from the original on 16 December 2015. Retrieved 25 July 2014.
"Fast Facts" (PDF). American Diabetes Association. Archived from the original (PDF) on 29 April 2015.

diabetesaustralia.com.au

static.diabetesaustralia.com.au

Shaw J (2012). "diabetes: the silent pandemic and its impact on Australia" (PDF). Archived (PDF) from the original on 7 October 2016. Retrieved 19 October 2016.

diabetesdaily.com

"WHAT IS TYPE 1 DIABETES?". Diabetes Daily. 18 April 2016.

diabeteswellness.net

"About DRWF". Diabetes Research & Wellness Foundation. Archived from the original on 11 May 2013.

doi.org

Zheng Y, Permanyer I, Canudas-Romo V, Aburto JM, Nigri A, Plana-Ripoll O (2023). "Lifespan variation among people with a given disease or condition". PLOS ONE. 18 (9): e0290962. Bibcode:2023PLoSO..1890962Z. doi:10.1371/journal.pone.0290962. ISSN 1932-6203. PMC 10473533. PMID 37656703.
Livingstone SJ, Levin D, Looker HC, Lindsay RS, Wild SH, Joss N, et al. (6 January 2015). "Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010". JAMA. 313 (1): 37–44. doi:10.1001/jama.2014.16425. ISSN 1538-3598. PMC 4426486. PMID 25562264.
Arffman M, Hakkarainen P, Keskimäki I, Oksanen T, Sund R (April 2023). "Long-term and recent trends in survival and life expectancy for people with type 1 diabetes in Finland". Diabetes Research and Clinical Practice. 198: 110580. doi:10.1016/j.diabres.2023.110580. ISSN 1872-8227. PMID 36804193.
Torpy JM, Lynm C, Glass RM (September 2007). "JAMA patient page. Type 1 diabetes". JAMA. 298 (12): 1472. doi:10.1001/jama.298.12.1472. PMID 17895465.
Chiang JL, Kirkman MS, Laffel LM, Peters AL (July 2014). "Type 1 diabetes through the life span: a position statement of the American Diabetes Association". Diabetes Care. 37 (7): 2034–2054. doi:10.2337/dc14-1140. PMC 5865481. PMID 24935775.
Daneman D (March 2006). "Type 1 diabetes". Lancet. 367 (9513): 847–858. doi:10.1016/S0140-6736(06)68341-4. PMID 16530579. S2CID 21485081.
Fang M, Wang D, Echouffo-Tcheugui JB, Selvin E (2023). "Age at Diagnosis in U.S. Adults With Type 1 Diabetes". Ann Intern Med. 176 (11): 1567–1568. doi:10.7326/M23-1707. PMC 10841362. PMID 37748184.
Wolsdorf & Garvey 2016, "Type 1 Diabetes". Wolsdorf JI, Garvey KC (2016). "Management of Diabetes in Children". Endocrinology: Adult and Pediatric. pp. 854–882.e6. doi:10.1016/B978-0-323-18907-1.00049-4. ISBN 978-0-323-18907-1.
DiMeglio, Evans-Molina & Oram 2018, p. 2449. DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
Katsarou et al. 2017, p. 1. Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, et al. (March 2017). "Type 1 diabetes mellitus". Nature Reviews. Disease Primers. 3: 17016. doi:10.1038/nrdp.2017.16. PMID 28358037. S2CID 23127616.
Katsarou et al. 2017, "Epidemiology". Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, et al. (March 2017). "Type 1 diabetes mellitus". Nature Reviews. Disease Primers. 3: 17016. doi:10.1038/nrdp.2017.16. PMID 28358037. S2CID 23127616.
Katsarou et al. 2017, "Introduction". Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, et al. (March 2017). "Type 1 diabetes mellitus". Nature Reviews. Disease Primers. 3: 17016. doi:10.1038/nrdp.2017.16. PMID 28358037. S2CID 23127616.
Knip M, Veijola R, Virtanen SM, Hyöty H, Vaarala O, Akerblom HK (December 2005). "Environmental triggers and determinants of type 1 diabetes". Diabetes. 54 (Suppl 2): S125–S136. doi:10.2337/diabetes.54.suppl_2.S125. PMID 16306330.
Norris, Johnson & Stene 2020, "Environmental factors". Norris JM, Johnson RK, Stene LC (March 2020). "Type 1 diabetes-early life origins and changing epidemiology". The Lancet. Diabetes & Endocrinology. 8 (3): 226–238. doi:10.1016/S2213-8587(19)30412-7. PMC 7332108. PMID 31999944.
Norris, Johnson & Stene 2020, "Trends in epidemiology". Norris JM, Johnson RK, Stene LC (March 2020). "Type 1 diabetes-early life origins and changing epidemiology". The Lancet. Diabetes & Endocrinology. 8 (3): 226–238. doi:10.1016/S2213-8587(19)30412-7. PMC 7332108. PMID 31999944.
Norris, Johnson & Stene 2020, "Infections". Norris JM, Johnson RK, Stene LC (March 2020). "Type 1 diabetes-early life origins and changing epidemiology". The Lancet. Diabetes & Endocrinology. 8 (3): 226–238. doi:10.1016/S2213-8587(19)30412-7. PMC 7332108. PMID 31999944.
Norris, Johnson & Stene 2020, "The hygiene hypothesis and proxies of microbial exposures". Norris JM, Johnson RK, Stene LC (March 2020). "Type 1 diabetes-early life origins and changing epidemiology". The Lancet. Diabetes & Endocrinology. 8 (3): 226–238. doi:10.1016/S2213-8587(19)30412-7. PMC 7332108. PMID 31999944.
DiMeglio, Evans-Molina & Oram 2018, p. 2450. DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
Repaske 2016, "Additional medications that decrease insulin release". Repaske DR (September 2016). "Medication-induced diabetes mellitus". Pediatr Diabetes. 17 (6): 392–7. doi:10.1111/pedi.12406. PMID 27492964. S2CID 4684512.
Repaske 2016, "A common medication that decreases insulin release". Repaske DR (September 2016). "Medication-induced diabetes mellitus". Pediatr Diabetes. 17 (6): 392–7. doi:10.1111/pedi.12406. PMID 27492964. S2CID 4684512.
American Diabetes Association (January 2021). "2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021". Diabetes Care. 44 (Suppl 1). American Diabetes Association: S15–S33. doi:10.2337/dc21-S002. PMID 33298413.
Butler & Misselbrook 2020, "What is the next investigation?". Butler AE, Misselbrook D (August 2020). "Distinguishing between type 1 and type 2 diabetes". The BMJ. 370: m2998. doi:10.1136/bmj.m2998. PMID 32784223. S2CID 221097632.
DiMeglio, Evans-Molina & Oram 2018, p. 2453. DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
Katsarou et al. 2017, p. 11. Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, et al. (March 2017). "Type 1 diabetes mellitus". Nature Reviews. Disease Primers. 3: 17016. doi:10.1038/nrdp.2017.16. PMID 28358037. S2CID 23127616.
American Diabetes Association (6) 2021, "Glycemic assessment". American Diabetes Association (January 2021). "6. Glycemic Targets: Standards of Medical Care in Diabetes-2021". Diabetes Care. 44 (Suppl 1): S73–S84. doi:10.2337/dc21-S006. PMID 33298417. S2CID 228087604.
DiMeglio, Evans-Molina & Oram 2018, "Management of clinical disease". DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
Lee TT, Collett C, Bergford S, Hartnell S, Scott EM, Lindsay RS, et al. (26 October 2023). "Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes". New England Journal of Medicine. 389 (17): 1566–1578. doi:10.1056/NEJMoa2303911. ISSN 0028-4793. PMID 37796241. Archived from the original on 5 November 2023. Retrieved 31 January 2024.{{cite journal}}: CS1 maint: bot: original URL status unknown (link)
"Closed-loop insulin systems are effective for pregnant women with type 1 diabetes". NIHR Evidence. 16 January 2024. doi:10.3310/nihrevidence_61786.
Seckold R, Fisher E, de Bock M, King BR, Smart CE (March 2019). "The ups and downs of low-carbohydrate diets in the management of Type 1 diabetes: a review of clinical outcomes". Diabetic Medicine (Review). 36 (3): 326–334. doi:10.1111/dme.13845. PMID 30362180. S2CID 53102654. Low‐carbohydrate diets are of interest for improving glycaemic outcomes in the management of Type 1 diabetes. There is limited evidence to support their routine use in the management of Type 1 diabetes.
Ly TT (2015). "Technology and type 1 diabetes: Closed-loop therapies". Current Pediatrics Reports. 3 (2): 170–176. doi:10.1007/s40124-015-0083-y. S2CID 68302123.
Robertson RP, Davis C, Larsen J, Stratta R, Sutherland DE (April 2006). "Pancreas and islet transplantation in type 1 diabetes". Diabetes Care. 29 (4): 935. doi:10.2337/diacare.29.04.06.dc06-9908. PMID 16567844.
Dean et al. 2017, "Simultaneous pancreas-kidney transplant". Dean PG, Kukla A, Stegall MD, Kudva YC (April 2017). "Pancreas transplantation". The BMJ. 357: j1321. doi:10.1136/bmj.j1321. PMID 28373161. S2CID 11374615.
Dean et al. 2017, "Outcomes of pancreas transplantation". Dean PG, Kukla A, Stegall MD, Kudva YC (April 2017). "Pancreas transplantation". The BMJ. 357: j1321. doi:10.1136/bmj.j1321. PMID 28373161. S2CID 11374615.
Shapiro, Pokrywczynska & Ricordi 2017, "Main". Shapiro AM, Pokrywczynska M, Ricordi C (May 2017). "Clinical pancreatic islet transplantation". Nat Rev Endocrinol. 13 (5): 268–277. doi:10.1038/nrendo.2016.178. PMID 27834384. S2CID 28784928.
Rickels & Robertson 2019, "Islet allotransplantation for the treatment of type 1 diabetes". Rickels MR, Robertson RP (April 2019). "Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions". Endocr Rev. 40 (2): 631–668. doi:10.1210/er.2018-00154. PMC 6424003. PMID 30541144.
Rickels & Robertson 2019, "Long-term outcomes and comparison with pancreas transplantation". Rickels MR, Robertson RP (April 2019). "Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions". Endocr Rev. 40 (2): 631–668. doi:10.1210/er.2018-00154. PMC 6424003. PMID 30541144.
Shapiro, Pokrywczynska & Ricordi 2017, "Indications for islet transplantation". Shapiro AM, Pokrywczynska M, Ricordi C (May 2017). "Clinical pancreatic islet transplantation". Nat Rev Endocrinol. 13 (5): 268–277. doi:10.1038/nrendo.2016.178. PMID 27834384. S2CID 28784928.
DiMeglio, Evans-Molina & Oram 2018, "The immune phenotype of type 1 diabetes". DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
DiMeglio, Evans-Molina & Oram 2018, "Diagnosis". DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
DiMeglio, Evans-Molina & Oram 2018, "The β-cell phenotype of type 1 diabetes". DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
Farhy LS, McCall AL (July 2015). "Glucagon – the new 'insulin' in the pathophysiology of diabetes". Current Opinion in Clinical Nutrition and Metabolic Care. 18 (4): 407–414. doi:10.1097/mco.0000000000000192. PMID 26049639. S2CID 19872862.
Yosten GL (February 2018). "Alpha cell dysfunction in type 1 diabetes". Peptides. 100: 54–60. doi:10.1016/j.peptides.2017.12.001. PMID 29412832. S2CID 46878644.
Brown RJ, Sinaii N, Rother KI (July 2008). "Too much glucagon, too little insulin: time course of pancreatic islet dysfunction in new-onset type 1 diabetes". Diabetes Care. 31 (7): 1403–1404. doi:10.2337/dc08-0575. PMC 2453684. PMID 18594062.
Unger RH, Cherrington AD (January 2012). "Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover". The Journal of Clinical Investigation. 122 (1): 4–12. doi:10.1172/JCI60016. PMC 3248306. PMID 22214853.
Meier JJ, Kjems LL, Veldhuis JD, Lefèbvre P, Butler PC (April 2006). "Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis". Diabetes. 55 (4): 1051–1056. doi:10.2337/diabetes.55.04.06.db05-1449. PMID 16567528.
Cooperberg BA, Cryer PE (December 2009). "Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans". Diabetes Care. 32 (12): 2275–2280. doi:10.2337/dc09-0798. PMC 2782990. PMID 19729529.
Paolisso G, Sgambato S, Torella R, Varricchio M, Scheen A, D'Onofrio F, et al. (June 1988). "Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type 1 diabetes". The Journal of Clinical Endocrinology and Metabolism. 66 (6): 1220–1226. doi:10.1210/jcem-66-6-1220. PMID 3286673.
Banarer S, McGregor VP, Cryer PE (April 2002). "Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response". Diabetes. 51 (4): 958–965. doi:10.2337/diabetes.51.4.958. PMID 11916913.
Raju B, Cryer PE (March 2005). "Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans". Diabetes. 54 (3): 757–764. doi:10.2337/diabetes.54.3.757. PMID 15734853.
Tesfaye N, Seaquist ER (November 2010). "Neuroendocrine responses to hypoglycemia". Annals of the New York Academy of Sciences. 1212 (1): 12–28. Bibcode:2010NYASA1212...12T. doi:10.1111/j.1749-6632.2010.05820.x. PMC 2991551. PMID 21039590.
Reno CM, Litvin M, Clark AL, Fisher SJ (March 2013). "Defective counterregulation and hypoglycemia unawareness in diabetes: mechanisms and emerging treatments". Endocrinology and Metabolism Clinics of North America. 42 (1): 15–38. doi:10.1016/j.ecl.2012.11.005. PMC 3568263. PMID 23391237.
Martín-Timón I, Del Cañizo-Gómez FJ (July 2015). "Mechanisms of hypoglycemia unawareness and implications in diabetic patients". World Journal of Diabetes. 6 (7): 912–926. doi:10.4239/wjd.v6.i7.912. PMC 4499525. PMID 26185599.
Mundinger TO, Taborsky GJ (October 2016). "Early sympathetic islet neuropathy in autoimmune diabetes: lessons learned and opportunities for investigation". Diabetologia. 59 (10): 2058–2067. doi:10.1007/s00125-016-4026-0. PMC 6214182. PMID 27342407.
Mundinger TO, Mei Q, Foulis AK, Fligner CL, Hull RL, Taborsky GJ (August 2016). "Human Type 1 Diabetes Is Characterized by an Early, Marked, Sustained, and Islet-Selective Loss of Sympathetic Nerves". Diabetes. 65 (8): 2322–2330. doi:10.2337/db16-0284. PMC 4955989. PMID 27207540.
DiMeglio, Evans-Molina & Oram 2018, p. 2455. DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
DiMeglio, Evans-Molina & Oram 2018, "Complications of type 1 diabetes". DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
Cashen & Petersen 2019, "Diagnosis, screening and prevention". Cashen K, Petersen T (August 2019). "Diabetic Ketoacidosis". Pediatr Rev. 40 (8): 412–420. doi:10.1542/pir.2018-0231. PMID 31371634. S2CID 199381655.
Cashen & Petersen 2019, "Epidemiology". Cashen K, Petersen T (August 2019). "Diabetic Ketoacidosis". Pediatr Rev. 40 (8): 412–420. doi:10.1542/pir.2018-0231. PMID 31371634. S2CID 199381655.
DiMeglio, Evans-Molina & Oram 2018, p. 2456. DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
Devaraj S, Glaser N, Griffen S, Wang-Polagruto J, Miguelino E, Jialal I (March 2006). "Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes". Diabetes. 55 (3): 774–779. doi:10.2337/diabetes.55.03.06.db05-1417. PMID 16505242.
Granberg V, Ejskjaer N, Peakman M, Sundkvist G (August 2005). "Autoantibodies to autonomic nerves associated with cardiac and peripheral autonomic neuropathy". Diabetes Care. 28 (8): 1959–1964. doi:10.2337/diacare.28.8.1959. PMID 16043739.
Huxley RR, Peters SA, Mishra GD, Woodward M (March 2015). "Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis". The Lancet. Diabetes & Endocrinology. 3 (3): 198–206. doi:10.1016/S2213-8587(14)70248-7. PMID 25660575.
Roy T, Lloyd CE (October 2012). "Epidemiology of depression and diabetes: a systematic review". Journal of Affective Disorders. 142 (Suppl): S8–21. doi:10.1016/S0165-0327(12)70004-6. PMID 23062861.
Elfström P, Sundström J, Ludvigsson JF (November 2014). "Systematic review with meta-analysis: associations between coeliac disease and type 1 diabetes". Alimentary Pharmacology & Therapeutics. 40 (10): 1123–1132. doi:10.1111/apt.12973. PMID 25270960. S2CID 25468009.
See JA, Kaukinen K, Makharia GK, Gibson PR, Murray JA (October 2015). "Practical insights into gluten-free diets". Nature Reviews. Gastroenterology & Hepatology (Review). 12 (10): 580–591. doi:10.1038/nrgastro.2015.156. PMID 26392070. S2CID 20270743. Coeliac disease in T1DM is asymptomatic ...Clinical manifestations of coeliac disease, such as abdominal pain, gas, bloating, diarrhoea and weight loss can be present in patients with T1DM, but are often attributed to poor control of diabetes, gastroparesis or diabetic neuropathy
Chen HS, Su LT, Lin SZ, Sung FC, Ko MC, Li CY (January 2012). "Increased risk of urinary tract calculi among patients with diabetes mellitus – a population-based cohort study". Urology. 79 (1): 86–92. doi:10.1016/j.urology.2011.07.1431. PMID 22119251.
James R, Hijaz A (October 2014). "Lower urinary tract symptoms in women with diabetes mellitus: a current review". Current Urology Reports. 15 (10): 440. doi:10.1007/s11934-014-0440-3. PMID 25118849. S2CID 30653959.
Goswami SK, Vishwanath M, Gangadarappa SK, Razdan R, Inamdar MN (August 2014). "Efficacy of ellagic acid and sildenafil in diabetes-induced sexual dysfunction". Pharmacognosy Magazine. 10 (Suppl 3): S581–S587. doi:10.4103/0973-1296.139790. PMC 4189276. PMID 25298678. ProQuest 1610759650.
Escobar-Morreale HF, Roldán B, Barrio R, Alonso M, Sancho J, de la Calle H, et al. (November 2000). "High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus". The Journal of Clinical Endocrinology and Metabolism. 85 (11): 4182–4187. doi:10.1210/jcem.85.11.6931. PMID 11095451.
Codner E, Escobar-Morreale HF (April 2007). "Clinical review: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus". The Journal of Clinical Endocrinology and Metabolism. 92 (4): 1209–1216. doi:10.1210/jc.2006-2641. PMID 17284617.
Redondo, Steck & Pugliese 2018, "Evidence for the contribution of genetics to type I diabetes". Redondo MJ, Steck AK, Pugliese A (May 2018). "Genetics of type 1 diabetes". Pediatric Diabetes. 19 (3): 346–353. doi:10.1111/pedi.12597. PMC 5918237. PMID 29094512.
von Scholten et al. 2021, "Antigen vaccination". von Scholten BJ, Kreiner FF, Gough SC, von Herrath M (May 2021). "Current and future therapies for type 1 diabetes". Diabetologia. 64 (5): 1037–1048. doi:10.1007/s00125-021-05398-3. PMC 8012324. PMID 33595677.
Dayan et al. 2019, "Previous prevention trials". Dayan CM, Korah M, Tatovic D, Bundy BN, Herold KC (October 2019). "Changing the landscape for type 1 diabetes: the first step to prevention". Lancet. 394 (10205): 1286–1296. doi:10.1016/S0140-6736(19)32127-0. PMID 31533907. S2CID 202575545.
Aanstoot HJ, Anderson BJ, Daneman D, Danne T, Donaghue K, Kaufman F, et al. (October 2007). "The global burden of youth diabetes: perspectives and potential". Pediatric Diabetes. 8. 8 (s8): 1–44. doi:10.1111/j.1399-5448.2007.00326.x. PMID 17767619. S2CID 222102948.
Weiss A, Donnachie E, Beyerlein A, Ziegler AG, Bonifacio E (22 May 2023). "Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19" (PDF). JAMA (Research Letter). 329 (23): 2089–2091. doi:10.1001/jama.2023.8674. PMC 10203966. PMID 37213115. S2CID 258831851.
Bottazzo GF, Florin-Christensen A, Doniach D (November 1974). "Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies". Lancet. 2 (7892): 1279–1283. doi:10.1016/s0140-6736(74)90140-8. PMID 4139522.
Herold KC, Vignali DA, Cooke A, Bluestone JA (April 2013). "Type 1 diabetes: translating mechanistic observations into effective clinical outcomes". Nature Reviews. Immunology. 13 (4): 243–256. doi:10.1038/nri3422. PMC 4172461. PMID 23524461.
Minami K, Seino S (March 2013). "Current status of regeneration of pancreatic β-cells". Journal of Diabetes Investigation. 4 (2): 131–141. doi:10.1111/jdi.12062. PMC 4019265. PMID 24843642.
Pagliuca FW, Millman JR, Gürtler M, Segel M, Van Dervort A, Ryu JH, et al. (October 2014). "Generation of functional human pancreatic β cells in vitro". Cell. 159 (2): 428–439. doi:10.1016/j.cell.2014.09.040. PMC 4617632. PMID 25303535.
Rezania A, Bruin JE, Arora P, Rubin A, Batushansky I, Asadi A, et al. (November 2014). "Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells". Nature Biotechnology. 32 (11): 1121–1133. doi:10.1038/nbt.3033. PMID 25211370. S2CID 205280579.
Boughton & Hovorka 2020, "Introduction". Boughton CK, Hovorka R (August 2020). "The artificial pancreas". Curr Opin Organ Transplant. 25 (4): 336–342. doi:10.1097/MOT.0000000000000786. PMID 32618719. S2CID 220326946.
Boughton & Hovorka 2020, "Regulatory Approval of Closed-Loop Systems". Boughton CK, Hovorka R (August 2020). "The artificial pancreas". Curr Opin Organ Transplant. 25 (4): 336–342. doi:10.1097/MOT.0000000000000786. PMID 32618719. S2CID 220326946.
Ramli R, Reddy M, Oliver N (July 2019). "Artificial Pancreas: Current Progress and Future Outlook in the Treatment of Type 1 Diabetes". Drugs. 79 (10): 1089–1101. doi:10.1007/s40265-019-01149-2. hdl:10044/1/71348. PMID 31190305. S2CID 186207231.
Pandey S, Dvorakova MC (7 January 2020). "Future Perspective of Diabetic Animal Models". Endocrine, Metabolic & Immune Disorders Drug Targets. 20 (1): 25–38. doi:10.2174/1871530319666190626143832. PMC 7360914. PMID 31241444.
Chen D, Thayer TC, Wen L, Wong FS (2020). "Mouse Models of Autoimmune Diabetes: The Nonobese Diabetic (NOD) Mouse". In King AJ (ed.). Animal Models of Diabetes. Methods in Molecular Biology. Vol. 2128. New York, NY: Springer US. pp. 87–92. doi:10.1007/978-1-0716-0385-7_6. ISBN 978-1-0716-0384-0. PMC 8253669. PMID 32180187.
Lenzen S, Arndt T, Elsner M, Wedekind D, Jörns A (2020). "Rat Models of Human Type 1 Diabetes". In King AJ (ed.). Animal Models of Diabetes. Methods in Molecular Biology. Vol. 2128. New York, NY: Springer US. pp. 69–85. doi:10.1007/978-1-0716-0385-7_5. ISBN 978-1-0716-0384-0. PMID 32180186. S2CID 212741496.
Al-Awar A, Kupai K, Veszelka M, Szűcs G, Attieh Z, Murlasits Z, et al. (2016). "Experimental Diabetes Mellitus in Different Animal Models". Journal of Diabetes Research. 2016: 9051426. doi:10.1155/2016/9051426. PMC 4993915. PMID 27595114.
Lenzen S, Tiedge M, Elsner M, Lortz S, Weiss H, Jörns A, et al. (September 2001). "The LEW.1AR1/Ztm-iddm rat: a new model of spontaneous insulin-dependent diabetes mellitus". Diabetologia. 44 (9): 1189–1196. doi:10.1007/s001250100625. PMID 11596676.
Lenzen S (October 2017). "Animal models of human type 1 diabetes for evaluating combination therapies and successful translation to the patient with type 1 diabetes". Diabetes/Metabolism Research and Reviews. 33 (7): e2915. doi:10.1002/dmrr.2915. PMID 28692149. S2CID 34331597.
Radenković M, Stojanović M, Prostran M (March 2016). "Experimental diabetes induced by alloxan and streptozotocin: The current state of the art". Journal of Pharmacological and Toxicological Methods. 78: 13–31. doi:10.1016/j.vascn.2015.11.004. PMID 26596652.
Salpea P, Cosentino C, Igoillo-Esteve M (2020). "A Review of Mouse Models of Monogenic Diabetes and ER Stress Signaling". In King AJ (ed.). Animal Models of Diabetes. Methods in Molecular Biology. Vol. 2128. New York, NY: Springer US. pp. 55–67. doi:10.1007/978-1-0716-0385-7_4. ISBN 978-1-0716-0384-0. PMID 32180185. S2CID 212740474.
Chang JH, Gurley SB (2012). "Assessment of Diabetic Nephropathy in the Akita Mouse". In Hans-Georg J, Hadi AH, Schürmann A (eds.). Animal Models in Diabetes Research. Methods in Molecular Biology. Vol. 933. Totowa, NJ: Humana Press. pp. 17–29. doi:10.1007/978-1-62703-068-7_2. ISBN 978-1-62703-067-0. PMID 22893398.
King AJ, Estil Les E, Montanya E (2020). "Use of Streptozotocin in Rodent Models of Islet Transplantation". In King AJ (ed.). Animal Models of Diabetes. Methods in Molecular Biology. Vol. 2128. New York, NY: Springer US. pp. 135–147. doi:10.1007/978-1-0716-0385-7_10. ISBN 978-1-0716-0384-0. PMID 32180191. S2CID 212739708.
Christoffersson G, Flodström-Tullberg M (2020). "Mouse Models of Virus-Induced Type 1 Diabetes". In King AJ (ed.). Animal Models of Diabetes. Methods in Molecular Biology. Vol. 2128. New York, NY: Springer US. pp. 93–105. doi:10.1007/978-1-0716-0385-7_7. ISBN 978-1-0716-0384-0. PMID 32180188. S2CID 212739248.
King AJ (June 2012). "The use of animal models in diabetes research". British Journal of Pharmacology. 166 (3): 877–894. doi:10.1111/j.1476-5381.2012.01911.x. PMC 3417415. PMID 22352879.

drugs.com

"FDA Approves Tzield". Drugs.com. November 2022. Retrieved 15 February 2023.

fda.gov

"FDA Approves First Cellular Therapy to Treat Patients with Type 1 Diabetes". U.S. Food and Drug Administration (FDA) (Press release). 28 June 2023. Retrieved 28 June 2023. This article incorporates text from this source, which is in the public domain.

handle.net

hdl.handle.net

Ramli R, Reddy M, Oliver N (July 2019). "Artificial Pancreas: Current Progress and Future Outlook in the Treatment of Type 1 Diabetes". Drugs. 79 (10): 1089–1101. doi:10.1007/s40265-019-01149-2. hdl:10044/1/71348. PMID 31190305. S2CID 186207231.

harvard.edu

ui.adsabs.harvard.edu

Zheng Y, Permanyer I, Canudas-Romo V, Aburto JM, Nigri A, Plana-Ripoll O (2023). "Lifespan variation among people with a given disease or condition". PLOS ONE. 18 (9): e0290962. Bibcode:2023PLoSO..1890962Z. doi:10.1371/journal.pone.0290962. ISSN 1932-6203. PMC 10473533. PMID 37656703.
Tesfaye N, Seaquist ER (November 2010). "Neuroendocrine responses to hypoglycemia". Annals of the New York Academy of Sciences. 1212 (1): 12–28. Bibcode:2010NYASA1212...12T. doi:10.1111/j.1749-6632.2010.05820.x. PMC 2991551. PMID 21039590.

jamanetwork.com

Weiss A, Donnachie E, Beyerlein A, Ziegler AG, Bonifacio E (22 May 2023). "Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19" (PDF). JAMA (Research Letter). 329 (23): 2089–2091. doi:10.1001/jama.2023.8674. PMC 10203966. PMID 37213115. S2CID 258831851.

jax.org

"NOD/ShiLtJ". The Jackson Laborataory. Retrieved 18 January 2022.

jdrf.org

"About JDRF". JDRF. Retrieved 24 March 2024.

nice.org.uk

"Overview | Diabetes in pregnancy: management from preconception to the postnatal period | Guidance | NICE". www.nice.org.uk. 25 February 2015. Retrieved 31 January 2024.

nih.gov

pubmed.ncbi.nlm.nih.gov

Zheng Y, Permanyer I, Canudas-Romo V, Aburto JM, Nigri A, Plana-Ripoll O (2023). "Lifespan variation among people with a given disease or condition". PLOS ONE. 18 (9): e0290962. Bibcode:2023PLoSO..1890962Z. doi:10.1371/journal.pone.0290962. ISSN 1932-6203. PMC 10473533. PMID 37656703.
Livingstone SJ, Levin D, Looker HC, Lindsay RS, Wild SH, Joss N, et al. (6 January 2015). "Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010". JAMA. 313 (1): 37–44. doi:10.1001/jama.2014.16425. ISSN 1538-3598. PMC 4426486. PMID 25562264.
Arffman M, Hakkarainen P, Keskimäki I, Oksanen T, Sund R (April 2023). "Long-term and recent trends in survival and life expectancy for people with type 1 diabetes in Finland". Diabetes Research and Clinical Practice. 198: 110580. doi:10.1016/j.diabres.2023.110580. ISSN 1872-8227. PMID 36804193.
Torpy JM, Lynm C, Glass RM (September 2007). "JAMA patient page. Type 1 diabetes". JAMA. 298 (12): 1472. doi:10.1001/jama.298.12.1472. PMID 17895465.
Chiang JL, Kirkman MS, Laffel LM, Peters AL (July 2014). "Type 1 diabetes through the life span: a position statement of the American Diabetes Association". Diabetes Care. 37 (7): 2034–2054. doi:10.2337/dc14-1140. PMC 5865481. PMID 24935775.
Daneman D (March 2006). "Type 1 diabetes". Lancet. 367 (9513): 847–858. doi:10.1016/S0140-6736(06)68341-4. PMID 16530579. S2CID 21485081.
Fang M, Wang D, Echouffo-Tcheugui JB, Selvin E (2023). "Age at Diagnosis in U.S. Adults With Type 1 Diabetes". Ann Intern Med. 176 (11): 1567–1568. doi:10.7326/M23-1707. PMC 10841362. PMID 37748184.
DiMeglio, Evans-Molina & Oram 2018, p. 2449. DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
Katsarou et al. 2017, p. 1. Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, et al. (March 2017). "Type 1 diabetes mellitus". Nature Reviews. Disease Primers. 3: 17016. doi:10.1038/nrdp.2017.16. PMID 28358037. S2CID 23127616.
Katsarou et al. 2017, "Epidemiology". Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, et al. (March 2017). "Type 1 diabetes mellitus". Nature Reviews. Disease Primers. 3: 17016. doi:10.1038/nrdp.2017.16. PMID 28358037. S2CID 23127616.
Katsarou et al. 2017, "Introduction". Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, et al. (March 2017). "Type 1 diabetes mellitus". Nature Reviews. Disease Primers. 3: 17016. doi:10.1038/nrdp.2017.16. PMID 28358037. S2CID 23127616.
Knip M, Veijola R, Virtanen SM, Hyöty H, Vaarala O, Akerblom HK (December 2005). "Environmental triggers and determinants of type 1 diabetes". Diabetes. 54 (Suppl 2): S125–S136. doi:10.2337/diabetes.54.suppl_2.S125. PMID 16306330.
Norris, Johnson & Stene 2020, "Environmental factors". Norris JM, Johnson RK, Stene LC (March 2020). "Type 1 diabetes-early life origins and changing epidemiology". The Lancet. Diabetes & Endocrinology. 8 (3): 226–238. doi:10.1016/S2213-8587(19)30412-7. PMC 7332108. PMID 31999944.
Norris, Johnson & Stene 2020, "Trends in epidemiology". Norris JM, Johnson RK, Stene LC (March 2020). "Type 1 diabetes-early life origins and changing epidemiology". The Lancet. Diabetes & Endocrinology. 8 (3): 226–238. doi:10.1016/S2213-8587(19)30412-7. PMC 7332108. PMID 31999944.
Norris, Johnson & Stene 2020, "Infections". Norris JM, Johnson RK, Stene LC (March 2020). "Type 1 diabetes-early life origins and changing epidemiology". The Lancet. Diabetes & Endocrinology. 8 (3): 226–238. doi:10.1016/S2213-8587(19)30412-7. PMC 7332108. PMID 31999944.
Norris, Johnson & Stene 2020, "The hygiene hypothesis and proxies of microbial exposures". Norris JM, Johnson RK, Stene LC (March 2020). "Type 1 diabetes-early life origins and changing epidemiology". The Lancet. Diabetes & Endocrinology. 8 (3): 226–238. doi:10.1016/S2213-8587(19)30412-7. PMC 7332108. PMID 31999944.
DiMeglio, Evans-Molina & Oram 2018, p. 2450. DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
Repaske 2016, "Additional medications that decrease insulin release". Repaske DR (September 2016). "Medication-induced diabetes mellitus". Pediatr Diabetes. 17 (6): 392–7. doi:10.1111/pedi.12406. PMID 27492964. S2CID 4684512.
Repaske 2016, "A common medication that decreases insulin release". Repaske DR (September 2016). "Medication-induced diabetes mellitus". Pediatr Diabetes. 17 (6): 392–7. doi:10.1111/pedi.12406. PMID 27492964. S2CID 4684512.
American Diabetes Association (January 2021). "2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021". Diabetes Care. 44 (Suppl 1). American Diabetes Association: S15–S33. doi:10.2337/dc21-S002. PMID 33298413.
Butler & Misselbrook 2020, "What is the next investigation?". Butler AE, Misselbrook D (August 2020). "Distinguishing between type 1 and type 2 diabetes". The BMJ. 370: m2998. doi:10.1136/bmj.m2998. PMID 32784223. S2CID 221097632.
DiMeglio, Evans-Molina & Oram 2018, p. 2453. DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
Katsarou et al. 2017, p. 11. Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, et al. (March 2017). "Type 1 diabetes mellitus". Nature Reviews. Disease Primers. 3: 17016. doi:10.1038/nrdp.2017.16. PMID 28358037. S2CID 23127616.
Smith & Harris 2018, "Self monitoring". Smith A, Harris C (August 2018). "Type 1 diabetes: Management strategies". American Family Physician. 98 (3): 154–156. PMID 30215903. Retrieved 12 January 2022.
American Diabetes Association (6) 2021, "Glycemic assessment". American Diabetes Association (January 2021). "6. Glycemic Targets: Standards of Medical Care in Diabetes-2021". Diabetes Care. 44 (Suppl 1): S73–S84. doi:10.2337/dc21-S006. PMID 33298417. S2CID 228087604.
DiMeglio, Evans-Molina & Oram 2018, "Management of clinical disease". DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
Lee TT, Collett C, Bergford S, Hartnell S, Scott EM, Lindsay RS, et al. (26 October 2023). "Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes". New England Journal of Medicine. 389 (17): 1566–1578. doi:10.1056/NEJMoa2303911. ISSN 0028-4793. PMID 37796241. Archived from the original on 5 November 2023. Retrieved 31 January 2024.{{cite journal}}: CS1 maint: bot: original URL status unknown (link)
Seckold R, Fisher E, de Bock M, King BR, Smart CE (March 2019). "The ups and downs of low-carbohydrate diets in the management of Type 1 diabetes: a review of clinical outcomes". Diabetic Medicine (Review). 36 (3): 326–334. doi:10.1111/dme.13845. PMID 30362180. S2CID 53102654. Low‐carbohydrate diets are of interest for improving glycaemic outcomes in the management of Type 1 diabetes. There is limited evidence to support their routine use in the management of Type 1 diabetes.
Robertson RP, Davis C, Larsen J, Stratta R, Sutherland DE (April 2006). "Pancreas and islet transplantation in type 1 diabetes". Diabetes Care. 29 (4): 935. doi:10.2337/diacare.29.04.06.dc06-9908. PMID 16567844.
Dean et al. 2017, "Simultaneous pancreas-kidney transplant". Dean PG, Kukla A, Stegall MD, Kudva YC (April 2017). "Pancreas transplantation". The BMJ. 357: j1321. doi:10.1136/bmj.j1321. PMID 28373161. S2CID 11374615.
Dean et al. 2017, "Outcomes of pancreas transplantation". Dean PG, Kukla A, Stegall MD, Kudva YC (April 2017). "Pancreas transplantation". The BMJ. 357: j1321. doi:10.1136/bmj.j1321. PMID 28373161. S2CID 11374615.
Shapiro, Pokrywczynska & Ricordi 2017, "Main". Shapiro AM, Pokrywczynska M, Ricordi C (May 2017). "Clinical pancreatic islet transplantation". Nat Rev Endocrinol. 13 (5): 268–277. doi:10.1038/nrendo.2016.178. PMID 27834384. S2CID 28784928.
Rickels & Robertson 2019, "Islet allotransplantation for the treatment of type 1 diabetes". Rickels MR, Robertson RP (April 2019). "Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions". Endocr Rev. 40 (2): 631–668. doi:10.1210/er.2018-00154. PMC 6424003. PMID 30541144.
Rickels & Robertson 2019, "Long-term outcomes and comparison with pancreas transplantation". Rickels MR, Robertson RP (April 2019). "Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions". Endocr Rev. 40 (2): 631–668. doi:10.1210/er.2018-00154. PMC 6424003. PMID 30541144.
Shapiro, Pokrywczynska & Ricordi 2017, "Indications for islet transplantation". Shapiro AM, Pokrywczynska M, Ricordi C (May 2017). "Clinical pancreatic islet transplantation". Nat Rev Endocrinol. 13 (5): 268–277. doi:10.1038/nrendo.2016.178. PMID 27834384. S2CID 28784928.
DiMeglio, Evans-Molina & Oram 2018, "The immune phenotype of type 1 diabetes". DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
DiMeglio, Evans-Molina & Oram 2018, "Diagnosis". DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
DiMeglio, Evans-Molina & Oram 2018, "The β-cell phenotype of type 1 diabetes". DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
Farhy LS, McCall AL (July 2015). "Glucagon – the new 'insulin' in the pathophysiology of diabetes". Current Opinion in Clinical Nutrition and Metabolic Care. 18 (4): 407–414. doi:10.1097/mco.0000000000000192. PMID 26049639. S2CID 19872862.
Yosten GL (February 2018). "Alpha cell dysfunction in type 1 diabetes". Peptides. 100: 54–60. doi:10.1016/j.peptides.2017.12.001. PMID 29412832. S2CID 46878644.
Brown RJ, Sinaii N, Rother KI (July 2008). "Too much glucagon, too little insulin: time course of pancreatic islet dysfunction in new-onset type 1 diabetes". Diabetes Care. 31 (7): 1403–1404. doi:10.2337/dc08-0575. PMC 2453684. PMID 18594062.
Unger RH, Cherrington AD (January 2012). "Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover". The Journal of Clinical Investigation. 122 (1): 4–12. doi:10.1172/JCI60016. PMC 3248306. PMID 22214853.
Meier JJ, Kjems LL, Veldhuis JD, Lefèbvre P, Butler PC (April 2006). "Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis". Diabetes. 55 (4): 1051–1056. doi:10.2337/diabetes.55.04.06.db05-1449. PMID 16567528.
Cooperberg BA, Cryer PE (December 2009). "Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans". Diabetes Care. 32 (12): 2275–2280. doi:10.2337/dc09-0798. PMC 2782990. PMID 19729529.
Paolisso G, Sgambato S, Torella R, Varricchio M, Scheen A, D'Onofrio F, et al. (June 1988). "Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type 1 diabetes". The Journal of Clinical Endocrinology and Metabolism. 66 (6): 1220–1226. doi:10.1210/jcem-66-6-1220. PMID 3286673.
Banarer S, McGregor VP, Cryer PE (April 2002). "Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response". Diabetes. 51 (4): 958–965. doi:10.2337/diabetes.51.4.958. PMID 11916913.
Raju B, Cryer PE (March 2005). "Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans". Diabetes. 54 (3): 757–764. doi:10.2337/diabetes.54.3.757. PMID 15734853.
Tesfaye N, Seaquist ER (November 2010). "Neuroendocrine responses to hypoglycemia". Annals of the New York Academy of Sciences. 1212 (1): 12–28. Bibcode:2010NYASA1212...12T. doi:10.1111/j.1749-6632.2010.05820.x. PMC 2991551. PMID 21039590.
Reno CM, Litvin M, Clark AL, Fisher SJ (March 2013). "Defective counterregulation and hypoglycemia unawareness in diabetes: mechanisms and emerging treatments". Endocrinology and Metabolism Clinics of North America. 42 (1): 15–38. doi:10.1016/j.ecl.2012.11.005. PMC 3568263. PMID 23391237.
Martín-Timón I, Del Cañizo-Gómez FJ (July 2015). "Mechanisms of hypoglycemia unawareness and implications in diabetic patients". World Journal of Diabetes. 6 (7): 912–926. doi:10.4239/wjd.v6.i7.912. PMC 4499525. PMID 26185599.
Mundinger TO, Taborsky GJ (October 2016). "Early sympathetic islet neuropathy in autoimmune diabetes: lessons learned and opportunities for investigation". Diabetologia. 59 (10): 2058–2067. doi:10.1007/s00125-016-4026-0. PMC 6214182. PMID 27342407.
Mundinger TO, Mei Q, Foulis AK, Fligner CL, Hull RL, Taborsky GJ (August 2016). "Human Type 1 Diabetes Is Characterized by an Early, Marked, Sustained, and Islet-Selective Loss of Sympathetic Nerves". Diabetes. 65 (8): 2322–2330. doi:10.2337/db16-0284. PMC 4955989. PMID 27207540.
DiMeglio, Evans-Molina & Oram 2018, p. 2455. DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
DiMeglio, Evans-Molina & Oram 2018, "Complications of type 1 diabetes". DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
Cashen & Petersen 2019, "Diagnosis, screening and prevention". Cashen K, Petersen T (August 2019). "Diabetic Ketoacidosis". Pediatr Rev. 40 (8): 412–420. doi:10.1542/pir.2018-0231. PMID 31371634. S2CID 199381655.
Cashen & Petersen 2019, "Epidemiology". Cashen K, Petersen T (August 2019). "Diabetic Ketoacidosis". Pediatr Rev. 40 (8): 412–420. doi:10.1542/pir.2018-0231. PMID 31371634. S2CID 199381655.
DiMeglio, Evans-Molina & Oram 2018, p. 2456. DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
Devaraj S, Glaser N, Griffen S, Wang-Polagruto J, Miguelino E, Jialal I (March 2006). "Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes". Diabetes. 55 (3): 774–779. doi:10.2337/diabetes.55.03.06.db05-1417. PMID 16505242.
Granberg V, Ejskjaer N, Peakman M, Sundkvist G (August 2005). "Autoantibodies to autonomic nerves associated with cardiac and peripheral autonomic neuropathy". Diabetes Care. 28 (8): 1959–1964. doi:10.2337/diacare.28.8.1959. PMID 16043739.
Huxley RR, Peters SA, Mishra GD, Woodward M (March 2015). "Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis". The Lancet. Diabetes & Endocrinology. 3 (3): 198–206. doi:10.1016/S2213-8587(14)70248-7. PMID 25660575.
Roy T, Lloyd CE (October 2012). "Epidemiology of depression and diabetes: a systematic review". Journal of Affective Disorders. 142 (Suppl): S8–21. doi:10.1016/S0165-0327(12)70004-6. PMID 23062861.
Elfström P, Sundström J, Ludvigsson JF (November 2014). "Systematic review with meta-analysis: associations between coeliac disease and type 1 diabetes". Alimentary Pharmacology & Therapeutics. 40 (10): 1123–1132. doi:10.1111/apt.12973. PMID 25270960. S2CID 25468009.
See JA, Kaukinen K, Makharia GK, Gibson PR, Murray JA (October 2015). "Practical insights into gluten-free diets". Nature Reviews. Gastroenterology & Hepatology (Review). 12 (10): 580–591. doi:10.1038/nrgastro.2015.156. PMID 26392070. S2CID 20270743. Coeliac disease in T1DM is asymptomatic ...Clinical manifestations of coeliac disease, such as abdominal pain, gas, bloating, diarrhoea and weight loss can be present in patients with T1DM, but are often attributed to poor control of diabetes, gastroparesis or diabetic neuropathy
Chen HS, Su LT, Lin SZ, Sung FC, Ko MC, Li CY (January 2012). "Increased risk of urinary tract calculi among patients with diabetes mellitus – a population-based cohort study". Urology. 79 (1): 86–92. doi:10.1016/j.urology.2011.07.1431. PMID 22119251.
James R, Hijaz A (October 2014). "Lower urinary tract symptoms in women with diabetes mellitus: a current review". Current Urology Reports. 15 (10): 440. doi:10.1007/s11934-014-0440-3. PMID 25118849. S2CID 30653959.
Goswami SK, Vishwanath M, Gangadarappa SK, Razdan R, Inamdar MN (August 2014). "Efficacy of ellagic acid and sildenafil in diabetes-induced sexual dysfunction". Pharmacognosy Magazine. 10 (Suppl 3): S581–S587. doi:10.4103/0973-1296.139790. PMC 4189276. PMID 25298678. ProQuest 1610759650.
Escobar-Morreale HF, Roldán B, Barrio R, Alonso M, Sancho J, de la Calle H, et al. (November 2000). "High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus". The Journal of Clinical Endocrinology and Metabolism. 85 (11): 4182–4187. doi:10.1210/jcem.85.11.6931. PMID 11095451.
Codner E, Escobar-Morreale HF (April 2007). "Clinical review: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus". The Journal of Clinical Endocrinology and Metabolism. 92 (4): 1209–1216. doi:10.1210/jc.2006-2641. PMID 17284617.
Redondo, Steck & Pugliese 2018, "Evidence for the contribution of genetics to type I diabetes". Redondo MJ, Steck AK, Pugliese A (May 2018). "Genetics of type 1 diabetes". Pediatric Diabetes. 19 (3): 346–353. doi:10.1111/pedi.12597. PMC 5918237. PMID 29094512.
von Scholten et al. 2021, "Antigen vaccination". von Scholten BJ, Kreiner FF, Gough SC, von Herrath M (May 2021). "Current and future therapies for type 1 diabetes". Diabetologia. 64 (5): 1037–1048. doi:10.1007/s00125-021-05398-3. PMC 8012324. PMID 33595677.
Dayan et al. 2019, "Previous prevention trials". Dayan CM, Korah M, Tatovic D, Bundy BN, Herold KC (October 2019). "Changing the landscape for type 1 diabetes: the first step to prevention". Lancet. 394 (10205): 1286–1296. doi:10.1016/S0140-6736(19)32127-0. PMID 31533907. S2CID 202575545.
Aanstoot HJ, Anderson BJ, Daneman D, Danne T, Donaghue K, Kaufman F, et al. (October 2007). "The global burden of youth diabetes: perspectives and potential". Pediatric Diabetes. 8. 8 (s8): 1–44. doi:10.1111/j.1399-5448.2007.00326.x. PMID 17767619. S2CID 222102948.
Weiss A, Donnachie E, Beyerlein A, Ziegler AG, Bonifacio E (22 May 2023). "Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19" (PDF). JAMA (Research Letter). 329 (23): 2089–2091. doi:10.1001/jama.2023.8674. PMC 10203966. PMID 37213115. S2CID 258831851.
Bottazzo GF, Florin-Christensen A, Doniach D (November 1974). "Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies". Lancet. 2 (7892): 1279–1283. doi:10.1016/s0140-6736(74)90140-8. PMID 4139522.
Herold KC, Vignali DA, Cooke A, Bluestone JA (April 2013). "Type 1 diabetes: translating mechanistic observations into effective clinical outcomes". Nature Reviews. Immunology. 13 (4): 243–256. doi:10.1038/nri3422. PMC 4172461. PMID 23524461.
Minami K, Seino S (March 2013). "Current status of regeneration of pancreatic β-cells". Journal of Diabetes Investigation. 4 (2): 131–141. doi:10.1111/jdi.12062. PMC 4019265. PMID 24843642.
Pagliuca FW, Millman JR, Gürtler M, Segel M, Van Dervort A, Ryu JH, et al. (October 2014). "Generation of functional human pancreatic β cells in vitro". Cell. 159 (2): 428–439. doi:10.1016/j.cell.2014.09.040. PMC 4617632. PMID 25303535.
Rezania A, Bruin JE, Arora P, Rubin A, Batushansky I, Asadi A, et al. (November 2014). "Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells". Nature Biotechnology. 32 (11): 1121–1133. doi:10.1038/nbt.3033. PMID 25211370. S2CID 205280579.
Boughton & Hovorka 2020, "Introduction". Boughton CK, Hovorka R (August 2020). "The artificial pancreas". Curr Opin Organ Transplant. 25 (4): 336–342. doi:10.1097/MOT.0000000000000786. PMID 32618719. S2CID 220326946.
Boughton & Hovorka 2020, "Regulatory Approval of Closed-Loop Systems". Boughton CK, Hovorka R (August 2020). "The artificial pancreas". Curr Opin Organ Transplant. 25 (4): 336–342. doi:10.1097/MOT.0000000000000786. PMID 32618719. S2CID 220326946.
Ramli R, Reddy M, Oliver N (July 2019). "Artificial Pancreas: Current Progress and Future Outlook in the Treatment of Type 1 Diabetes". Drugs. 79 (10): 1089–1101. doi:10.1007/s40265-019-01149-2. hdl:10044/1/71348. PMID 31190305. S2CID 186207231.
Pandey S, Dvorakova MC (7 January 2020). "Future Perspective of Diabetic Animal Models". Endocrine, Metabolic & Immune Disorders Drug Targets. 20 (1): 25–38. doi:10.2174/1871530319666190626143832. PMC 7360914. PMID 31241444.
Chen D, Thayer TC, Wen L, Wong FS (2020). "Mouse Models of Autoimmune Diabetes: The Nonobese Diabetic (NOD) Mouse". In King AJ (ed.). Animal Models of Diabetes. Methods in Molecular Biology. Vol. 2128. New York, NY: Springer US. pp. 87–92. doi:10.1007/978-1-0716-0385-7_6. ISBN 978-1-0716-0384-0. PMC 8253669. PMID 32180187.
Lenzen S, Arndt T, Elsner M, Wedekind D, Jörns A (2020). "Rat Models of Human Type 1 Diabetes". In King AJ (ed.). Animal Models of Diabetes. Methods in Molecular Biology. Vol. 2128. New York, NY: Springer US. pp. 69–85. doi:10.1007/978-1-0716-0385-7_5. ISBN 978-1-0716-0384-0. PMID 32180186. S2CID 212741496.
Al-Awar A, Kupai K, Veszelka M, Szűcs G, Attieh Z, Murlasits Z, et al. (2016). "Experimental Diabetes Mellitus in Different Animal Models". Journal of Diabetes Research. 2016: 9051426. doi:10.1155/2016/9051426. PMC 4993915. PMID 27595114.
Lenzen S, Tiedge M, Elsner M, Lortz S, Weiss H, Jörns A, et al. (September 2001). "The LEW.1AR1/Ztm-iddm rat: a new model of spontaneous insulin-dependent diabetes mellitus". Diabetologia. 44 (9): 1189–1196. doi:10.1007/s001250100625. PMID 11596676.
Lenzen S (October 2017). "Animal models of human type 1 diabetes for evaluating combination therapies and successful translation to the patient with type 1 diabetes". Diabetes/Metabolism Research and Reviews. 33 (7): e2915. doi:10.1002/dmrr.2915. PMID 28692149. S2CID 34331597.
Radenković M, Stojanović M, Prostran M (March 2016). "Experimental diabetes induced by alloxan and streptozotocin: The current state of the art". Journal of Pharmacological and Toxicological Methods. 78: 13–31. doi:10.1016/j.vascn.2015.11.004. PMID 26596652.
Salpea P, Cosentino C, Igoillo-Esteve M (2020). "A Review of Mouse Models of Monogenic Diabetes and ER Stress Signaling". In King AJ (ed.). Animal Models of Diabetes. Methods in Molecular Biology. Vol. 2128. New York, NY: Springer US. pp. 55–67. doi:10.1007/978-1-0716-0385-7_4. ISBN 978-1-0716-0384-0. PMID 32180185. S2CID 212740474.
Chang JH, Gurley SB (2012). "Assessment of Diabetic Nephropathy in the Akita Mouse". In Hans-Georg J, Hadi AH, Schürmann A (eds.). Animal Models in Diabetes Research. Methods in Molecular Biology. Vol. 933. Totowa, NJ: Humana Press. pp. 17–29. doi:10.1007/978-1-62703-068-7_2. ISBN 978-1-62703-067-0. PMID 22893398.
King AJ, Estil Les E, Montanya E (2020). "Use of Streptozotocin in Rodent Models of Islet Transplantation". In King AJ (ed.). Animal Models of Diabetes. Methods in Molecular Biology. Vol. 2128. New York, NY: Springer US. pp. 135–147. doi:10.1007/978-1-0716-0385-7_10. ISBN 978-1-0716-0384-0. PMID 32180191. S2CID 212739708.
Christoffersson G, Flodström-Tullberg M (2020). "Mouse Models of Virus-Induced Type 1 Diabetes". In King AJ (ed.). Animal Models of Diabetes. Methods in Molecular Biology. Vol. 2128. New York, NY: Springer US. pp. 93–105. doi:10.1007/978-1-0716-0385-7_7. ISBN 978-1-0716-0384-0. PMID 32180188. S2CID 212739248.
King AJ (June 2012). "The use of animal models in diabetes research". British Journal of Pharmacology. 166 (3): 877–894. doi:10.1111/j.1476-5381.2012.01911.x. PMC 3417415. PMID 22352879.

ncbi.nlm.nih.gov

Zheng Y, Permanyer I, Canudas-Romo V, Aburto JM, Nigri A, Plana-Ripoll O (2023). "Lifespan variation among people with a given disease or condition". PLOS ONE. 18 (9): e0290962. Bibcode:2023PLoSO..1890962Z. doi:10.1371/journal.pone.0290962. ISSN 1932-6203. PMC 10473533. PMID 37656703.
Livingstone SJ, Levin D, Looker HC, Lindsay RS, Wild SH, Joss N, et al. (6 January 2015). "Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010". JAMA. 313 (1): 37–44. doi:10.1001/jama.2014.16425. ISSN 1538-3598. PMC 4426486. PMID 25562264.
Chiang JL, Kirkman MS, Laffel LM, Peters AL (July 2014). "Type 1 diabetes through the life span: a position statement of the American Diabetes Association". Diabetes Care. 37 (7): 2034–2054. doi:10.2337/dc14-1140. PMC 5865481. PMID 24935775.
Fang M, Wang D, Echouffo-Tcheugui JB, Selvin E (2023). "Age at Diagnosis in U.S. Adults With Type 1 Diabetes". Ann Intern Med. 176 (11): 1567–1568. doi:10.7326/M23-1707. PMC 10841362. PMID 37748184.
DiMeglio, Evans-Molina & Oram 2018, p. 2449. DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
Norris, Johnson & Stene 2020, "Environmental factors". Norris JM, Johnson RK, Stene LC (March 2020). "Type 1 diabetes-early life origins and changing epidemiology". The Lancet. Diabetes & Endocrinology. 8 (3): 226–238. doi:10.1016/S2213-8587(19)30412-7. PMC 7332108. PMID 31999944.
Norris, Johnson & Stene 2020, "Trends in epidemiology". Norris JM, Johnson RK, Stene LC (March 2020). "Type 1 diabetes-early life origins and changing epidemiology". The Lancet. Diabetes & Endocrinology. 8 (3): 226–238. doi:10.1016/S2213-8587(19)30412-7. PMC 7332108. PMID 31999944.
Norris, Johnson & Stene 2020, "Infections". Norris JM, Johnson RK, Stene LC (March 2020). "Type 1 diabetes-early life origins and changing epidemiology". The Lancet. Diabetes & Endocrinology. 8 (3): 226–238. doi:10.1016/S2213-8587(19)30412-7. PMC 7332108. PMID 31999944.
Norris, Johnson & Stene 2020, "The hygiene hypothesis and proxies of microbial exposures". Norris JM, Johnson RK, Stene LC (March 2020). "Type 1 diabetes-early life origins and changing epidemiology". The Lancet. Diabetes & Endocrinology. 8 (3): 226–238. doi:10.1016/S2213-8587(19)30412-7. PMC 7332108. PMID 31999944.
DiMeglio, Evans-Molina & Oram 2018, p. 2450. DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
DiMeglio, Evans-Molina & Oram 2018, p. 2453. DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
DiMeglio, Evans-Molina & Oram 2018, "Management of clinical disease". DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
Rickels & Robertson 2019, "Islet allotransplantation for the treatment of type 1 diabetes". Rickels MR, Robertson RP (April 2019). "Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions". Endocr Rev. 40 (2): 631–668. doi:10.1210/er.2018-00154. PMC 6424003. PMID 30541144.
Rickels & Robertson 2019, "Long-term outcomes and comparison with pancreas transplantation". Rickels MR, Robertson RP (April 2019). "Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions". Endocr Rev. 40 (2): 631–668. doi:10.1210/er.2018-00154. PMC 6424003. PMID 30541144.
DiMeglio, Evans-Molina & Oram 2018, "The immune phenotype of type 1 diabetes". DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
DiMeglio, Evans-Molina & Oram 2018, "Diagnosis". DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
DiMeglio, Evans-Molina & Oram 2018, "The β-cell phenotype of type 1 diabetes". DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
Brown RJ, Sinaii N, Rother KI (July 2008). "Too much glucagon, too little insulin: time course of pancreatic islet dysfunction in new-onset type 1 diabetes". Diabetes Care. 31 (7): 1403–1404. doi:10.2337/dc08-0575. PMC 2453684. PMID 18594062.
Unger RH, Cherrington AD (January 2012). "Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover". The Journal of Clinical Investigation. 122 (1): 4–12. doi:10.1172/JCI60016. PMC 3248306. PMID 22214853.
Cooperberg BA, Cryer PE (December 2009). "Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans". Diabetes Care. 32 (12): 2275–2280. doi:10.2337/dc09-0798. PMC 2782990. PMID 19729529.
Tesfaye N, Seaquist ER (November 2010). "Neuroendocrine responses to hypoglycemia". Annals of the New York Academy of Sciences. 1212 (1): 12–28. Bibcode:2010NYASA1212...12T. doi:10.1111/j.1749-6632.2010.05820.x. PMC 2991551. PMID 21039590.
Reno CM, Litvin M, Clark AL, Fisher SJ (March 2013). "Defective counterregulation and hypoglycemia unawareness in diabetes: mechanisms and emerging treatments". Endocrinology and Metabolism Clinics of North America. 42 (1): 15–38. doi:10.1016/j.ecl.2012.11.005. PMC 3568263. PMID 23391237.
Martín-Timón I, Del Cañizo-Gómez FJ (July 2015). "Mechanisms of hypoglycemia unawareness and implications in diabetic patients". World Journal of Diabetes. 6 (7): 912–926. doi:10.4239/wjd.v6.i7.912. PMC 4499525. PMID 26185599.
Mundinger TO, Taborsky GJ (October 2016). "Early sympathetic islet neuropathy in autoimmune diabetes: lessons learned and opportunities for investigation". Diabetologia. 59 (10): 2058–2067. doi:10.1007/s00125-016-4026-0. PMC 6214182. PMID 27342407.
Mundinger TO, Mei Q, Foulis AK, Fligner CL, Hull RL, Taborsky GJ (August 2016). "Human Type 1 Diabetes Is Characterized by an Early, Marked, Sustained, and Islet-Selective Loss of Sympathetic Nerves". Diabetes. 65 (8): 2322–2330. doi:10.2337/db16-0284. PMC 4955989. PMID 27207540.
DiMeglio, Evans-Molina & Oram 2018, p. 2455. DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
DiMeglio, Evans-Molina & Oram 2018, "Complications of type 1 diabetes". DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
DiMeglio, Evans-Molina & Oram 2018, p. 2456. DiMeglio LA, Evans-Molina C, Oram RA (June 2018). "Type 1 diabetes". Lancet. 391 (10138): 2449–2462. doi:10.1016/S0140-6736(18)31320-5. PMC 6661119. PMID 29916386.
Goswami SK, Vishwanath M, Gangadarappa SK, Razdan R, Inamdar MN (August 2014). "Efficacy of ellagic acid and sildenafil in diabetes-induced sexual dysfunction". Pharmacognosy Magazine. 10 (Suppl 3): S581–S587. doi:10.4103/0973-1296.139790. PMC 4189276. PMID 25298678. ProQuest 1610759650.
Redondo, Steck & Pugliese 2018, "Evidence for the contribution of genetics to type I diabetes". Redondo MJ, Steck AK, Pugliese A (May 2018). "Genetics of type 1 diabetes". Pediatric Diabetes. 19 (3): 346–353. doi:10.1111/pedi.12597. PMC 5918237. PMID 29094512.
von Scholten et al. 2021, "Antigen vaccination". von Scholten BJ, Kreiner FF, Gough SC, von Herrath M (May 2021). "Current and future therapies for type 1 diabetes". Diabetologia. 64 (5): 1037–1048. doi:10.1007/s00125-021-05398-3. PMC 8012324. PMID 33595677.
Weiss A, Donnachie E, Beyerlein A, Ziegler AG, Bonifacio E (22 May 2023). "Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19" (PDF). JAMA (Research Letter). 329 (23): 2089–2091. doi:10.1001/jama.2023.8674. PMC 10203966. PMID 37213115. S2CID 258831851.
Herold KC, Vignali DA, Cooke A, Bluestone JA (April 2013). "Type 1 diabetes: translating mechanistic observations into effective clinical outcomes". Nature Reviews. Immunology. 13 (4): 243–256. doi:10.1038/nri3422. PMC 4172461. PMID 23524461.
Minami K, Seino S (March 2013). "Current status of regeneration of pancreatic β-cells". Journal of Diabetes Investigation. 4 (2): 131–141. doi:10.1111/jdi.12062. PMC 4019265. PMID 24843642.
Pagliuca FW, Millman JR, Gürtler M, Segel M, Van Dervort A, Ryu JH, et al. (October 2014). "Generation of functional human pancreatic β cells in vitro". Cell. 159 (2): 428–439. doi:10.1016/j.cell.2014.09.040. PMC 4617632. PMID 25303535.
Pandey S, Dvorakova MC (7 January 2020). "Future Perspective of Diabetic Animal Models". Endocrine, Metabolic & Immune Disorders Drug Targets. 20 (1): 25–38. doi:10.2174/1871530319666190626143832. PMC 7360914. PMID 31241444.
Chen D, Thayer TC, Wen L, Wong FS (2020). "Mouse Models of Autoimmune Diabetes: The Nonobese Diabetic (NOD) Mouse". In King AJ (ed.). Animal Models of Diabetes. Methods in Molecular Biology. Vol. 2128. New York, NY: Springer US. pp. 87–92. doi:10.1007/978-1-0716-0385-7_6. ISBN 978-1-0716-0384-0. PMC 8253669. PMID 32180187.
Al-Awar A, Kupai K, Veszelka M, Szűcs G, Attieh Z, Murlasits Z, et al. (2016). "Experimental Diabetes Mellitus in Different Animal Models". Journal of Diabetes Research. 2016: 9051426. doi:10.1155/2016/9051426. PMC 4993915. PMID 27595114.
King AJ (June 2012). "The use of animal models in diabetes research". British Journal of Pharmacology. 166 (3): 877–894. doi:10.1111/j.1476-5381.2012.01911.x. PMC 3417415. PMID 22352879.

niddk.nih.gov

"Types of Diabetes". NIDDK. February 2014. Archived from the original on 16 August 2016. Retrieved 31 July 2016.
"Causes of Diabetes". NIDDK. August 2014. Archived from the original on 10 August 2016. Retrieved 31 July 2016.
"Diagnosis of Diabetes and Prediabetes". NIDDK. May 2015. Archived from the original on 16 August 2016. Retrieved 31 July 2016.
"Alternative Devices for Taking Insulin". NIDDK. July 2016. Archived from the original on 16 August 2016. Retrieved 31 July 2016.

nihr.ac.uk

evidence.nihr.ac.uk

"Closed-loop insulin systems are effective for pregnant women with type 1 diabetes". NIHR Evidence. 16 January 2024. doi:10.3310/nihrevidence_61786.

proquest.com

search.proquest.com

Goswami SK, Vishwanath M, Gangadarappa SK, Razdan R, Inamdar MN (August 2014). "Efficacy of ellagic acid and sildenafil in diabetes-induced sexual dysfunction". Pharmacognosy Magazine. 10 (Suppl 3): S581–S587. doi:10.4103/0973-1296.139790. PMC 4189276. PMID 25298678. ProQuest 1610759650.

semanticscholar.org

api.semanticscholar.org

Daneman D (March 2006). "Type 1 diabetes". Lancet. 367 (9513): 847–858. doi:10.1016/S0140-6736(06)68341-4. PMID 16530579. S2CID 21485081.
Katsarou et al. 2017, p. 1. Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, et al. (March 2017). "Type 1 diabetes mellitus". Nature Reviews. Disease Primers. 3: 17016. doi:10.1038/nrdp.2017.16. PMID 28358037. S2CID 23127616.
Katsarou et al. 2017, "Epidemiology". Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, et al. (March 2017). "Type 1 diabetes mellitus". Nature Reviews. Disease Primers. 3: 17016. doi:10.1038/nrdp.2017.16. PMID 28358037. S2CID 23127616.
Katsarou et al. 2017, "Introduction". Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, et al. (March 2017). "Type 1 diabetes mellitus". Nature Reviews. Disease Primers. 3: 17016. doi:10.1038/nrdp.2017.16. PMID 28358037. S2CID 23127616.
Repaske 2016, "Additional medications that decrease insulin release". Repaske DR (September 2016). "Medication-induced diabetes mellitus". Pediatr Diabetes. 17 (6): 392–7. doi:10.1111/pedi.12406. PMID 27492964. S2CID 4684512.
Repaske 2016, "A common medication that decreases insulin release". Repaske DR (September 2016). "Medication-induced diabetes mellitus". Pediatr Diabetes. 17 (6): 392–7. doi:10.1111/pedi.12406. PMID 27492964. S2CID 4684512.
Butler & Misselbrook 2020, "What is the next investigation?". Butler AE, Misselbrook D (August 2020). "Distinguishing between type 1 and type 2 diabetes". The BMJ. 370: m2998. doi:10.1136/bmj.m2998. PMID 32784223. S2CID 221097632.
Katsarou et al. 2017, p. 11. Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, et al. (March 2017). "Type 1 diabetes mellitus". Nature Reviews. Disease Primers. 3: 17016. doi:10.1038/nrdp.2017.16. PMID 28358037. S2CID 23127616.
American Diabetes Association (6) 2021, "Glycemic assessment". American Diabetes Association (January 2021). "6. Glycemic Targets: Standards of Medical Care in Diabetes-2021". Diabetes Care. 44 (Suppl 1): S73–S84. doi:10.2337/dc21-S006. PMID 33298417. S2CID 228087604.
Seckold R, Fisher E, de Bock M, King BR, Smart CE (March 2019). "The ups and downs of low-carbohydrate diets in the management of Type 1 diabetes: a review of clinical outcomes". Diabetic Medicine (Review). 36 (3): 326–334. doi:10.1111/dme.13845. PMID 30362180. S2CID 53102654. Low‐carbohydrate diets are of interest for improving glycaemic outcomes in the management of Type 1 diabetes. There is limited evidence to support their routine use in the management of Type 1 diabetes.
Ly TT (2015). "Technology and type 1 diabetes: Closed-loop therapies". Current Pediatrics Reports. 3 (2): 170–176. doi:10.1007/s40124-015-0083-y. S2CID 68302123.
Dean et al. 2017, "Simultaneous pancreas-kidney transplant". Dean PG, Kukla A, Stegall MD, Kudva YC (April 2017). "Pancreas transplantation". The BMJ. 357: j1321. doi:10.1136/bmj.j1321. PMID 28373161. S2CID 11374615.
Dean et al. 2017, "Outcomes of pancreas transplantation". Dean PG, Kukla A, Stegall MD, Kudva YC (April 2017). "Pancreas transplantation". The BMJ. 357: j1321. doi:10.1136/bmj.j1321. PMID 28373161. S2CID 11374615.
Shapiro, Pokrywczynska & Ricordi 2017, "Main". Shapiro AM, Pokrywczynska M, Ricordi C (May 2017). "Clinical pancreatic islet transplantation". Nat Rev Endocrinol. 13 (5): 268–277. doi:10.1038/nrendo.2016.178. PMID 27834384. S2CID 28784928.
Shapiro, Pokrywczynska & Ricordi 2017, "Indications for islet transplantation". Shapiro AM, Pokrywczynska M, Ricordi C (May 2017). "Clinical pancreatic islet transplantation". Nat Rev Endocrinol. 13 (5): 268–277. doi:10.1038/nrendo.2016.178. PMID 27834384. S2CID 28784928.
Farhy LS, McCall AL (July 2015). "Glucagon – the new 'insulin' in the pathophysiology of diabetes". Current Opinion in Clinical Nutrition and Metabolic Care. 18 (4): 407–414. doi:10.1097/mco.0000000000000192. PMID 26049639. S2CID 19872862.
Yosten GL (February 2018). "Alpha cell dysfunction in type 1 diabetes". Peptides. 100: 54–60. doi:10.1016/j.peptides.2017.12.001. PMID 29412832. S2CID 46878644.
Cashen & Petersen 2019, "Diagnosis, screening and prevention". Cashen K, Petersen T (August 2019). "Diabetic Ketoacidosis". Pediatr Rev. 40 (8): 412–420. doi:10.1542/pir.2018-0231. PMID 31371634. S2CID 199381655.
Cashen & Petersen 2019, "Epidemiology". Cashen K, Petersen T (August 2019). "Diabetic Ketoacidosis". Pediatr Rev. 40 (8): 412–420. doi:10.1542/pir.2018-0231. PMID 31371634. S2CID 199381655.
Elfström P, Sundström J, Ludvigsson JF (November 2014). "Systematic review with meta-analysis: associations between coeliac disease and type 1 diabetes". Alimentary Pharmacology & Therapeutics. 40 (10): 1123–1132. doi:10.1111/apt.12973. PMID 25270960. S2CID 25468009.
See JA, Kaukinen K, Makharia GK, Gibson PR, Murray JA (October 2015). "Practical insights into gluten-free diets". Nature Reviews. Gastroenterology & Hepatology (Review). 12 (10): 580–591. doi:10.1038/nrgastro.2015.156. PMID 26392070. S2CID 20270743. Coeliac disease in T1DM is asymptomatic ...Clinical manifestations of coeliac disease, such as abdominal pain, gas, bloating, diarrhoea and weight loss can be present in patients with T1DM, but are often attributed to poor control of diabetes, gastroparesis or diabetic neuropathy
James R, Hijaz A (October 2014). "Lower urinary tract symptoms in women with diabetes mellitus: a current review". Current Urology Reports. 15 (10): 440. doi:10.1007/s11934-014-0440-3. PMID 25118849. S2CID 30653959.
Dayan et al. 2019, "Previous prevention trials". Dayan CM, Korah M, Tatovic D, Bundy BN, Herold KC (October 2019). "Changing the landscape for type 1 diabetes: the first step to prevention". Lancet. 394 (10205): 1286–1296. doi:10.1016/S0140-6736(19)32127-0. PMID 31533907. S2CID 202575545.
Aanstoot HJ, Anderson BJ, Daneman D, Danne T, Donaghue K, Kaufman F, et al. (October 2007). "The global burden of youth diabetes: perspectives and potential". Pediatric Diabetes. 8. 8 (s8): 1–44. doi:10.1111/j.1399-5448.2007.00326.x. PMID 17767619. S2CID 222102948.
Weiss A, Donnachie E, Beyerlein A, Ziegler AG, Bonifacio E (22 May 2023). "Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19" (PDF). JAMA (Research Letter). 329 (23): 2089–2091. doi:10.1001/jama.2023.8674. PMC 10203966. PMID 37213115. S2CID 258831851.
Rezania A, Bruin JE, Arora P, Rubin A, Batushansky I, Asadi A, et al. (November 2014). "Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells". Nature Biotechnology. 32 (11): 1121–1133. doi:10.1038/nbt.3033. PMID 25211370. S2CID 205280579.
Boughton & Hovorka 2020, "Introduction". Boughton CK, Hovorka R (August 2020). "The artificial pancreas". Curr Opin Organ Transplant. 25 (4): 336–342. doi:10.1097/MOT.0000000000000786. PMID 32618719. S2CID 220326946.
Boughton & Hovorka 2020, "Regulatory Approval of Closed-Loop Systems". Boughton CK, Hovorka R (August 2020). "The artificial pancreas". Curr Opin Organ Transplant. 25 (4): 336–342. doi:10.1097/MOT.0000000000000786. PMID 32618719. S2CID 220326946.
Ramli R, Reddy M, Oliver N (July 2019). "Artificial Pancreas: Current Progress and Future Outlook in the Treatment of Type 1 Diabetes". Drugs. 79 (10): 1089–1101. doi:10.1007/s40265-019-01149-2. hdl:10044/1/71348. PMID 31190305. S2CID 186207231.
Lenzen S, Arndt T, Elsner M, Wedekind D, Jörns A (2020). "Rat Models of Human Type 1 Diabetes". In King AJ (ed.). Animal Models of Diabetes. Methods in Molecular Biology. Vol. 2128. New York, NY: Springer US. pp. 69–85. doi:10.1007/978-1-0716-0385-7_5. ISBN 978-1-0716-0384-0. PMID 32180186. S2CID 212741496.
Lenzen S (October 2017). "Animal models of human type 1 diabetes for evaluating combination therapies and successful translation to the patient with type 1 diabetes". Diabetes/Metabolism Research and Reviews. 33 (7): e2915. doi:10.1002/dmrr.2915. PMID 28692149. S2CID 34331597.
Salpea P, Cosentino C, Igoillo-Esteve M (2020). "A Review of Mouse Models of Monogenic Diabetes and ER Stress Signaling". In King AJ (ed.). Animal Models of Diabetes. Methods in Molecular Biology. Vol. 2128. New York, NY: Springer US. pp. 55–67. doi:10.1007/978-1-0716-0385-7_4. ISBN 978-1-0716-0384-0. PMID 32180185. S2CID 212740474.
King AJ, Estil Les E, Montanya E (2020). "Use of Streptozotocin in Rodent Models of Islet Transplantation". In King AJ (ed.). Animal Models of Diabetes. Methods in Molecular Biology. Vol. 2128. New York, NY: Springer US. pp. 135–147. doi:10.1007/978-1-0716-0385-7_10. ISBN 978-1-0716-0384-0. PMID 32180191. S2CID 212739708.
Christoffersson G, Flodström-Tullberg M (2020). "Mouse Models of Virus-Induced Type 1 Diabetes". In King AJ (ed.). Animal Models of Diabetes. Methods in Molecular Biology. Vol. 2128. New York, NY: Springer US. pp. 93–105. doi:10.1007/978-1-0716-0385-7_7. ISBN 978-1-0716-0384-0. PMID 32180188. S2CID 212739248.

usatoday.com

Johnson L (18 November 2008). "Study: Cost of diabetes $218B". USA Today. Associated Press. Archived from the original on 1 July 2012.

web.archive.org

"Diabetes". World Health Organization. Archived from the original on 26 January 2011. Retrieved 24 January 2011.
"Diabetes Fact sheet N°312". WHO. November 2016. Archived from the original on 26 August 2013. Retrieved 29 May 2017.
"Types of Diabetes". NIDDK. February 2014. Archived from the original on 16 August 2016. Retrieved 31 July 2016.
"Causes of Diabetes". NIDDK. August 2014. Archived from the original on 10 August 2016. Retrieved 31 July 2016.
"Diagnosis of Diabetes and Prediabetes". NIDDK. May 2015. Archived from the original on 16 August 2016. Retrieved 31 July 2016.
"Alternative Devices for Taking Insulin". NIDDK. July 2016. Archived from the original on 16 August 2016. Retrieved 31 July 2016.
"Fast Facts Data and Statistics about Diabetes". American Diabetes Association. Archived from the original on 16 December 2015. Retrieved 25 July 2014.
Global report on diabetes (PDF). World Health Organization. 2016. pp. 26–27. ISBN 978-92-4-156525-7. Archived (PDF) from the original on 7 October 2016. Retrieved 31 July 2016.
Skyler J (2012). Atlas of diabetes (4th ed.). New York: Springer. pp. 67–68. ISBN 978-1-4614-1028-7. Archived from the original on 8 September 2017.
Lee TT, Collett C, Bergford S, Hartnell S, Scott EM, Lindsay RS, et al. (26 October 2023). "Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes". New England Journal of Medicine. 389 (17): 1566–1578. doi:10.1056/NEJMoa2303911. ISSN 0028-4793. PMID 37796241. Archived from the original on 5 November 2023. Retrieved 31 January 2024.{{cite journal}}: CS1 maint: bot: original URL status unknown (link)
"Stress". diabetes.org. American Diabetes Association. Archived from the original on 12 November 2014. Retrieved 11 November 2014.
"Sexual Dysfunction in Women". Diabetes.co.uk. Diabetes Digital Media Ltd. Archived from the original on 9 November 2014. Retrieved 28 November 2014.
"Fast Facts" (PDF). American Diabetes Association. Archived from the original (PDF) on 29 April 2015.
Australian Institute of Health and Welfare (2015). "Incidence of type 1 diabetes in Australia 2000–2013". Archived from the original on 7 October 2016. Retrieved 19 October 2016.
Shaw J (2012). "diabetes: the silent pandemic and its impact on Australia" (PDF). Archived (PDF) from the original on 7 October 2016. Retrieved 19 October 2016.
Johnson L (18 November 2008). "Study: Cost of diabetes $218B". USA Today. Associated Press. Archived from the original on 1 July 2012.
"About DRWF". Diabetes Research & Wellness Foundation. Archived from the original on 11 May 2013.

who.int

"Diabetes". World Health Organization. Archived from the original on 26 January 2011. Retrieved 24 January 2011.
"Diabetes Fact sheet N°312". WHO. November 2016. Archived from the original on 26 August 2013. Retrieved 29 May 2017.
Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia (PDF). Geneva: World Health Organization. 2006. p. 1. ISBN 978-92-4-159493-6. Retrieved 28 July 2021.

apps.who.int

Global report on diabetes (PDF). World Health Organization. 2016. pp. 26–27. ISBN 978-92-4-156525-7. Archived (PDF) from the original on 7 October 2016. Retrieved 31 July 2016.

worldcat.org

Zheng Y, Permanyer I, Canudas-Romo V, Aburto JM, Nigri A, Plana-Ripoll O (2023). "Lifespan variation among people with a given disease or condition". PLOS ONE. 18 (9): e0290962. Bibcode:2023PLoSO..1890962Z. doi:10.1371/journal.pone.0290962. ISSN 1932-6203. PMC 10473533. PMID 37656703.
Livingstone SJ, Levin D, Looker HC, Lindsay RS, Wild SH, Joss N, et al. (6 January 2015). "Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010". JAMA. 313 (1): 37–44. doi:10.1001/jama.2014.16425. ISSN 1538-3598. PMC 4426486. PMID 25562264.
Arffman M, Hakkarainen P, Keskimäki I, Oksanen T, Sund R (April 2023). "Long-term and recent trends in survival and life expectancy for people with type 1 diabetes in Finland". Diabetes Research and Clinical Practice. 198: 110580. doi:10.1016/j.diabres.2023.110580. ISSN 1872-8227. PMID 36804193.
Lee TT, Collett C, Bergford S, Hartnell S, Scott EM, Lindsay RS, et al. (26 October 2023). "Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes". New England Journal of Medicine. 389 (17): 1566–1578. doi:10.1056/NEJMoa2303911. ISSN 0028-4793. PMID 37796241. Archived from the original on 5 November 2023. Retrieved 31 January 2024.{{cite journal}}: CS1 maint: bot: original URL status unknown (link)
King AJ (2020). Animal models of diabetes: methods and protocols. New York, NY: Humana Press. ISBN 978-1-0716-0385-7. OCLC 1149391907.^{[page needed]}